🇺🇸 FDA

Company profile · Sponsor

Jiangsu

Jiangsu Province Centers for Disease Control and Prevention

CCEEE1D · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Jiangsu (CCEEE1D) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CCEEE1D
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. H. pylori vaccine

    Jiangsu

    H. Pylori Infection

    phase 3 mab completed

    1 trial

  2. Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28

    Jiangsu

    COVID-19

    phase 1 mab completed

    1 trial

Frequently asked questions

What is Jiangsu?

Jiangsu (CCEEE1D) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Jiangsu sponsor?

We track 2 ClinicalTrials.gov-linked programs for Jiangsu, including H. pylori vaccine and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Jiangsu company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.